
    
      A Placebo-controlled, Randomized, Double-blind, Multi-center, Phase 3 Study to Evaluate the
      Efficacy and Safety of Intravenous Administration of 'IV-Globulin S inj.(Human Immunoglobulin
      G)' as an Adjuvant Therapy in Adult Subjects with Community-Acquired Severe Sepsis or Septic
      Shock.
    
  